OCULAR THERAPEUTIX, INC (OCUL)
Latest OCUL Insider Trades
About OCULAR THERAPEUTIX, INC (OCUL)
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
- BEDFORD, MA
- 325
- 2014
- XNAS
90-Day SEC Filing Activity
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 44,705 | $444K |
| Grant or award | 14 | 377,465 | |
| Bona-fide gift | 4 | 200,368 |
OCUL Insider Transactions (Form 4)
4557 Form 4 filings on record, the earliest from Oct 4, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Peter Kaiser - Officer | Open-market sale | Common Stock | 3,035 |
Recent OCUL Form 8-K Filings
4Recent OCUL Form 144 Notices of Proposed Sale
3A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| JEFFREY S. HEIER | Officer | 3,296 | $36K | View on EDGAR | |
| PRAVIN DUGEL | Officer |
OCUL Insider Trading - FAQ
What is the latest insider trade for OCUL?
OCULAR THERAPEUTIX, INC (OCUL) had 13 insider filings in the last 90 days, with the most recent on 2026-08-26. The full record for OCUL runs to 57 Form 4 filings, the earliest from 2024-10-04. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
How many insiders are buying OCUL stock?
No insider purchases of OCUL were filed in the last 90 days. 2 purchases are on record for this company.
How many insiders are selling OCUL stock?
5 insider sales of OCUL were filed in the last 90 days, totaling $444K.
Where can I see OCUL SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page tracks OCUL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
How can I follow OCUL insider buys?
Create a free InsiderAlpha account and press Watch on this page to add OCUL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
More Health Care Companies with Insider Activity
Recent Insider Filings
10Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
- - Peter Kaiser view on EDGAR
- - Sanjay Nayak view on EDGAR
- - Jeffrey S. Heier view on EDGAR
- - Pravin Dugel view on EDGAR
- - Pravin Dugel view on EDGAR
- - Charles M. Warden view on EDGAR
- - Adrienne L. Graves view on EDGAR
- - Jason Shand Robins view on EDGAR
- - Seung Suh Hong view on EDGAR
Related Companies - Recent Insider Activity
Learn More
- What is SEC Form 4?
- The filing insiders must submit within two business days of a trade, and how to read its transaction codes.
- Insider activity in Health Care
- Where OCUL's peers are being bought and sold.
- Every recent Form 4
- The full market-wide feed, updated as filings arrive from SEC EDGAR.
Track OCUL insider activity as it files
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
